Zequn Niu

429 citations
24 papers · 335 indexed · h-index 13

Zequn Niu

23 papers receiving 331 citations

Peers

Zequn Niu
Comparison fields: 5 of 73
  • Cancer Research 163
  • Molecular Biology 227
  • Immunology 41
  • Biochemistry 13
  • Nephrology 12
Replace Yanghe Zhang with:
Yanghe Zhang China
Xiao-Ya Lou China
Qingfei Meng China
Xuanming Pan China
Ziqi Cheng China
Youguang Huang China
Hongmei You China
Yawei Huang China
Jialin Feng China
Zequn Niu relative to Yanghe Zhang China Yanghe Zhang's profile →
Citations per field
00.5×7.5×
Yanghe Zhang · 1×
Citations per year

Countries citing papers authored by Zequn Niu

Since Specialization
Citations

This map shows the geographic impact of Zequn Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zequn Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zequn Niu more than expected).

Fields of papers citing papers by Zequn Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zequn Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zequn Niu. The network helps show where Zequn Niu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zequn Niu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zequn Niu Line = papers co-authored together Zequn Niu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 202215
3 20214
4 202128
5 202126
6 20217
7 202013
8 20190
9 201913
10 201926
11 201731
12 201645
13 20161
14
The role of JAK/STAT3 signaling pathway on apoptosis of lung adenocarcinoma cell line PC-9 induced by icotinib.
201610
15
Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.
201416
16 20142
17
Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma.
201426
18 201313
19 20137
20 201312

About Zequn Niu

Zequn Niu is a scholar working on Cancer Research, Immunology and Nephrology, having authored 24 papers that have together received 335 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Pancreatitis Pathology and Treatment (6 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Phagocytosis and Immune Regulation (3 papers), Circular RNAs in diseases (3 papers), RNA Research and Splicing (3 papers) and Mycobacterium research and diagnosis (2 papers). The work is most often cited by research in Cancer Research (163 citations), Molecular Biology (227 citations) and Immunology (41 citations). Zequn Niu has collaborated with scholars based in China and United States. Frequent co-authors include Longfei Pan, Shuanying Yang, Honghong Pei, Rui Zhang, Xiaoyan Dang, Yuping Zhang, Wei Li, Zongjuan Ming, Liming Wang and Meng Xia. Their work appears in journals such as Oncotarget, Journal of Cellular and Molecular Medicine, Archives of Medical Research, Cell Transplantation and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026